Literature DB >> 25288092

Rifampin induces hydroxyl radical formation in Mycobacterium tuberculosis.

Giovanni Piccaro1, Donatella Pietraforte2, Federico Giannoni1, Alessandro Mustazzolu1, Lanfranco Fattorini3.   

Abstract

The antituberculosis (anti-TB) drug rifampin (RIF) binds to the beta subunit of the RNA polymerase (RpoB) of Mycobacterium tuberculosis, but the bactericidal responses triggered after target interaction are not known. To evaluate whether RIF induced an oxidative burst, lysates of RIF-treated M. tuberculosis were tested for determination of reactive oxygen species (ROS) by the electron paramagnetic resonance (EPR) technique using 1-hydroxy-3-carboxy-pyrrolidine (CPH) and 5,5-dimethyl-1-pyrrolidine-N-oxide (DMPO) as spin traps. M. tuberculosis killing by RIF stimulated an increase in the rate of formation of the CPH radical (CP·). Lysate pretreatment with the O2·(-) and ·OH scavengers superoxide dismutase (SOD) and thiourea (THIO), respectively, or with the metal chelator diethylene triamine pentaacetic acid (DTPA) inhibited CP· formation, arguing in favor of a metal-catalyzed ROS response. Formation of CP· did not increase following treatment of RIF-resistant strains with RIF, indicating that the ROS were induced after RpoB binding. To identify the ROS formed, lysates of RIF-treated bacilli were incubated with DMPO, a spin trap specific for ·OH and O2·(-), with or without pretreatment with SOD, catalase, THIO, or DTPA. Superoxide dismutase, catalase, and THIO decreased formation of the DMPO-OH adduct, and SOD plus DTPA completely suppressed it, suggesting that RIF activated metal-dependent O2·(-)-mediated mechanisms producing ·OH inside tubercle bacilli. The finding that the metal chelator DTPA reduced the bactericidal activity of RIF supported the possibility that ·OH was generated through these mechanisms and that it participated at least in part in M. tuberculosis killing by the drug.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25288092      PMCID: PMC4249506          DOI: 10.1128/AAC.03169-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals.

Authors:  Sarah Schmidt Grant; Benjamin B Kaufmann; Nikhilesh S Chand; Nathan Haseley; Deborah T Hung
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

2.  Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis isolates in Spain and their rapid detection by PCR-enzyme-linked immunosorbent assay.

Authors:  L Garcia; M Alonso-Sanz; M J Rebollo; J C Tercero; F Chaves
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Inhibitors of reactive oxygen species accumulation delay and/or reduce the lethality of several antistaphylococcal agents.

Authors:  Yuanli Liu; Xinghan Liu; Yilin Qu; Xiuhong Wang; Liping Li; Xilin Zhao
Journal:  Antimicrob Agents Chemother       Date:  2012-09-04       Impact factor: 5.191

Review 4.  Advances in the development of new tuberculosis drugs and treatment regimens.

Authors:  Alimuddin Zumla; Payam Nahid; Stewart T Cole
Journal:  Nat Rev Drug Discov       Date:  2013-05       Impact factor: 84.694

5.  Host cell autophagy activated by antibiotics is required for their effective antimycobacterial drug action.

Authors:  Jwa-Jin Kim; Hye-Mi Lee; Dong-Min Shin; Wonho Kim; Jae-Min Yuk; Hyo Sun Jin; Sang-Hee Lee; Guang-Ho Cha; Jin-Man Kim; Zee-Won Lee; Sung Jae Shin; Heekyung Yoo; Young Kil Park; Jin Bong Park; Jongkyeong Chung; Tamotsu Yoshimori; Eun-Kyeong Jo
Journal:  Cell Host Microbe       Date:  2012-05-17       Impact factor: 21.023

6.  Metal-independent production of hydroxyl radicals by halogenated quinones and hydrogen peroxide: an ESR spin trapping study.

Authors:  Ben-Zhan Zhu; Hong-Tao Zhao; Balaraman Kalyanaraman; Balz Frei
Journal:  Free Radic Biol Med       Date:  2002-03-01       Impact factor: 7.376

7.  Spin-trapping and human neutrophils. Limits of detection of hydroxyl radical.

Authors:  S Pou; M S Cohen; B E Britigan; G M Rosen
Journal:  J Biol Chem       Date:  1989-07-25       Impact factor: 5.157

8.  Isoniazid: Radical-induced oxidation and reduction chemistry.

Authors:  Kimberly A Rickman; Katy L Swancutt; Stephen P Mezyk; James J Kiddle
Journal:  Bioorg Med Chem Lett       Date:  2013-03-13       Impact factor: 2.823

9.  Mycobacterium tuberculosis is extraordinarily sensitive to killing by a vitamin C-induced Fenton reaction.

Authors:  Catherine Vilchèze; Travis Hartman; Brian Weinrick; William R Jacobs
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Reengineering redox sensitive GFP to measure mycothiol redox potential of Mycobacterium tuberculosis during infection.

Authors:  Ashima Bhaskar; Manbeena Chawla; Mansi Mehta; Pankti Parikh; Pallavi Chandra; Devayani Bhave; Dhiraj Kumar; Kate S Carroll; Amit Singh
Journal:  PLoS Pathog       Date:  2014-01-30       Impact factor: 6.823

View more
  33 in total

1.  A Screen for Antibiotic Resistance Determinants Reveals a Fitness Cost of the Flagellum in Pseudomonas aeruginosa.

Authors:  E A Rundell; N Commodore; A L Goodman; B I Kazmierczak
Journal:  J Bacteriol       Date:  2020-02-25       Impact factor: 3.490

2.  De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs In Vitro.

Authors:  Jees Sebastian; Sharmada Swaminath; Rashmi Ravindran Nair; Kishor Jakkala; Atul Pradhan; Parthasarathi Ajitkumar
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

3.  Host-pathogen redox dynamics modulate Mycobacterium tuberculosis pathogenesis.

Authors:  Hayden T Pacl; Vineel P Reddy; Vikram Saini; Krishna C Chinta; Adrie J C Steyn
Journal:  Pathog Dis       Date:  2018-07-01       Impact factor: 3.166

4.  Understanding lipidomic basis of iron limitation induced chemosensitization of drug-resistant Mycobacterium tuberculosis.

Authors:  Rahul Pal; Saif Hameed; Parveen Kumar; Sarman Singh; Zeeshan Fatima
Journal:  3 Biotech       Date:  2019-03-05       Impact factor: 2.406

5.  Involvement of the SCO3366 efflux pump from S. coelicolor in rifampicin resistance and its regulation by a TetR regulator.

Authors:  Ankita Nag; Sarika Mehra
Journal:  Appl Microbiol Biotechnol       Date:  2022-02-23       Impact factor: 4.813

6.  L-GSH Supplementation in Conjunction With Rifampicin Augments the Treatment Response to Mycobacterium tuberculosis in a Diabetic Mouse Model.

Authors:  Abrianna Beever; Nala Kachour; James Owens; Kayvan Sasaninia; Afsal Kolloli; Ranjeet Kumar; Santhamani Ramasamy; Christina Sisliyan; Wael Khamas; Selvakumar Subbian; Vishwanath Venketaraman
Journal:  Front Pharmacol       Date:  2022-06-24       Impact factor: 5.988

7.  Rifampicin-Mediated Metabolic Changes in Mycobacterium tuberculosis.

Authors:  Soujanya D Yelamanchi; Archita Mishra; Santosh Kumar Behra; Gayathree Karthikkeyan; Thottethodi Subrahmanya Keshava Prasad; Avadhesha Surolia
Journal:  Metabolites       Date:  2022-05-29

8.  Elevated Levels of Three Reactive Oxygen Species and Fe(II) in the Antibiotic-Surviving Population of Mycobacteria Facilitate De Novo Emergence of Genetic Resisters to Antibiotics.

Authors:  Avraneel Paul; Rashmi Ravindran Nair; Kishor Jakkala; Atul Pradhan; Parthasarathi Ajitkumar
Journal:  Antimicrob Agents Chemother       Date:  2022-04-18       Impact factor: 5.938

9.  Tuberculosis: Today's researches-tomorrow's therapies.

Authors:  Amit Singh; Avadhesha Surolia
Journal:  IUBMB Life       Date:  2018-08-18       Impact factor: 3.885

10.  Proteasome Accessory Factor C (pafC) Is a novel gene Involved in Mycobacterium Intrinsic Resistance to broad-spectrum antibiotics--Fluoroquinolones.

Authors:  Qiming Li; Longxiang Xie; Quanxin Long; Jinxiao Mao; Hui Li; Mingliang Zhou; Jianping Xie
Journal:  Sci Rep       Date:  2015-07-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.